This is an opportunity to join a global company with a good UK presence aiming to, connect Science to Patients.
They are a cutting edge translational technology company, therefore they bring clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, inflammation, cardiovascular and metabolic disease drug discovery.
This is an excellent opportunity, based in Leicestershire for you to develop close working relationships with key stakeholders; to manage projects which may entail inVitro & in Vivio techniques whilst managing their sponsors expectations and requirements.
They are looking to recruit an experienced and motivated Study Director to join and lead a collaborative research project team. You will be an experienced manager with the ability to coach and develop their more junior members of the team.
You will have a proven track record and expertise in areas of design, implementation and analysis of in vivo and in vitro data. You will be responsible for reviewing pre-clinical data and reports to monitor overall clinical data quality.
- Qualification in biology or Science related subject PHD or equivalent
- Experience in Oncology-related animal studies, ideally small molecules and biologics
- Experience in biochemical science with immunology / inflammation / Oncology research
In return, they offer excellent training and career development as well as highly competitive salary and benefits.
If you can work collaboratively with the in vivo & in vitro team, & apply your expertise to delivering effective studies using a wide range of Vivo models such as metastasis and traditional subcutaneous modules, we would like to hear from you.
This company is an Equal Opportunities employer and welcomes applications from all who meet their selection criteria. If you do not hear back from them within 10 working days of your application for this role, it means that on this occasion you have not been shortlisted for the next stage of the recruitment campaign. Entitlement to work in the EEA is essential.